[Criteria for treating MRSA in sputum].

about

[Criteria for treating MRSA in sputum].

Item

http://www.wikidata.org/entity/Q50002566

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[Criteria for treating MRSA in sputum].

@en

[Criteria for treating MRSA in sputum].

@nl

type

Item

label

[Criteria for treating MRSA in sputum].

@en

[Criteria for treating MRSA in sputum].

@nl

prefLabel

[Criteria for treating MRSA in sputum].

@en

[Criteria for treating MRSA in sputum].

@nl

P1476

[Criteria for treating MRSA in sputum].

@en

P2093

B Schaaf

http://www.w3.org/2001/XMLSchema#string

J Lorenz

http://www.w3.org/2001/XMLSchema#string

M Unnewehr

http://www.w3.org/2001/XMLSchema#string

S Gatermann

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis

Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis.

Carriage of Staphylococcus aureus: epidemiology and clinical relevance.

Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis.

Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practice

Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.

[New antibacterial agents on the market and in the pipeline].

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients.

Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus.

Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study.

P304

1127-1132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00108-017-0328-7

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28929236

http://www.w3.org/2001/XMLSchema#string

P921

sputum